Quintiles announces completed acquisition of Novella Clinical
Quintiles is the world's biggest provider of biopharmaceutical development and commercial outsourcing services. It has a network of more than 27,000 workers and conducts business in around 100 countries.
Today, Quintiles said it had completed acquisition of the previously announced purchase for Novella Clinical. The latter is a full service clinical research organization that is primarily focused on emerging oncology clients. Novella Clinical also offers services to those in the medical device and diagnostics sectors.
According to Paula Brown Stafford, president, Clinical Development at Quintiles said, "We are extremely pleased to have completed the acquisition of Novella and look forward to working together to increase our collective opportunities with emerging oncology and medical device companies. With the transaction now officially closed, we will focus our efforts on leveraging Quintiles' global resources and capabilities with the expertise and personal attention of Novella to continue to deliver the high-quality services customers have come to expect from both companies."